Cargando…

The Direction of Tumour Growth in Glioblastoma Patients

Generating MR-derived growth pattern models for glioblastoma multiforme (GBM) has been an attractive approach in neuro-oncology, suggesting a distinct pattern of lesion spread with a tendency in growing along the white matter (WM) fibre direction for the invasive component. However, the direction of...

Descripción completa

Detalles Bibliográficos
Autores principales: Esmaeili, Morteza, Stensjøen, Anne Line, Berntsen, Erik Magnus, Solheim, Ole, Reinertsen, Ingerid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775193/
https://www.ncbi.nlm.nih.gov/pubmed/29352231
http://dx.doi.org/10.1038/s41598-018-19420-z
_version_ 1783293849217531904
author Esmaeili, Morteza
Stensjøen, Anne Line
Berntsen, Erik Magnus
Solheim, Ole
Reinertsen, Ingerid
author_facet Esmaeili, Morteza
Stensjøen, Anne Line
Berntsen, Erik Magnus
Solheim, Ole
Reinertsen, Ingerid
author_sort Esmaeili, Morteza
collection PubMed
description Generating MR-derived growth pattern models for glioblastoma multiforme (GBM) has been an attractive approach in neuro-oncology, suggesting a distinct pattern of lesion spread with a tendency in growing along the white matter (WM) fibre direction for the invasive component. However, the direction of growth is not much studied in vivo. In this study, we sought to study the dominant directions of tumour expansion/shrinkage pre-treatment. We examined fifty-six GBMs at two time-points: at radiological diagnosis and as part of the pre-operative planning, both with contrast-enhanced T1-weighted MRIs. The tumour volumes were semi-automatically segmented. A non-linear registration resulting in a deformation field characterizing the changes between the two time points was used together with the segmented tumours to determine the dominant directions of tumour change. To compute the degree of alignment between tumour growth vectors and WM fibres, an angle map was calculated. Our results demonstrate that tumours tend to grow predominantly along the WM, as evidenced by the dominant vector population with the maximum alignments. Our findings represent a step forward in investigating the hypothesis that tumour cells tend to migrate preferentially along the WM.
format Online
Article
Text
id pubmed-5775193
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-57751932018-01-26 The Direction of Tumour Growth in Glioblastoma Patients Esmaeili, Morteza Stensjøen, Anne Line Berntsen, Erik Magnus Solheim, Ole Reinertsen, Ingerid Sci Rep Article Generating MR-derived growth pattern models for glioblastoma multiforme (GBM) has been an attractive approach in neuro-oncology, suggesting a distinct pattern of lesion spread with a tendency in growing along the white matter (WM) fibre direction for the invasive component. However, the direction of growth is not much studied in vivo. In this study, we sought to study the dominant directions of tumour expansion/shrinkage pre-treatment. We examined fifty-six GBMs at two time-points: at radiological diagnosis and as part of the pre-operative planning, both with contrast-enhanced T1-weighted MRIs. The tumour volumes were semi-automatically segmented. A non-linear registration resulting in a deformation field characterizing the changes between the two time points was used together with the segmented tumours to determine the dominant directions of tumour change. To compute the degree of alignment between tumour growth vectors and WM fibres, an angle map was calculated. Our results demonstrate that tumours tend to grow predominantly along the WM, as evidenced by the dominant vector population with the maximum alignments. Our findings represent a step forward in investigating the hypothesis that tumour cells tend to migrate preferentially along the WM. Nature Publishing Group UK 2018-01-19 /pmc/articles/PMC5775193/ /pubmed/29352231 http://dx.doi.org/10.1038/s41598-018-19420-z Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Esmaeili, Morteza
Stensjøen, Anne Line
Berntsen, Erik Magnus
Solheim, Ole
Reinertsen, Ingerid
The Direction of Tumour Growth in Glioblastoma Patients
title The Direction of Tumour Growth in Glioblastoma Patients
title_full The Direction of Tumour Growth in Glioblastoma Patients
title_fullStr The Direction of Tumour Growth in Glioblastoma Patients
title_full_unstemmed The Direction of Tumour Growth in Glioblastoma Patients
title_short The Direction of Tumour Growth in Glioblastoma Patients
title_sort direction of tumour growth in glioblastoma patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775193/
https://www.ncbi.nlm.nih.gov/pubmed/29352231
http://dx.doi.org/10.1038/s41598-018-19420-z
work_keys_str_mv AT esmaeilimorteza thedirectionoftumourgrowthinglioblastomapatients
AT stensjøenanneline thedirectionoftumourgrowthinglioblastomapatients
AT berntsenerikmagnus thedirectionoftumourgrowthinglioblastomapatients
AT solheimole thedirectionoftumourgrowthinglioblastomapatients
AT reinertseningerid thedirectionoftumourgrowthinglioblastomapatients
AT esmaeilimorteza directionoftumourgrowthinglioblastomapatients
AT stensjøenanneline directionoftumourgrowthinglioblastomapatients
AT berntsenerikmagnus directionoftumourgrowthinglioblastomapatients
AT solheimole directionoftumourgrowthinglioblastomapatients
AT reinertseningerid directionoftumourgrowthinglioblastomapatients